Bipolar Disorder - Current and Future Players Summary GlobalData has released its pharma report, "Bipolar Disorder - Current and Future Players". The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Bipolar Disorder Market. The report identifies and analyses the key companies shaping and driving the global Bipolar Disorder market. The report provides insight into the competitive Bipolar Disorder landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData's team of industry experts. *This is an on-demand report and will be delivered within 24 hrs. (excluding weekends) of the purchase. Scope - Investigation of current and future market competition for Bipolar Disorder - Competitor assessment - Coverage of key market players and company profiles including business description, financial overview and SWOT analysis. - Strategic assessment of Bipolar Disorder sector through market impact analysis, future market scenario and company analysis Reasons To Buy - Gain a high level view of the trends shaping and driving Bipolar Disorder market - Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition. - Create an effective counter-strategy to gain a competitive advantage against those currently in the market - What's the next big thing in the global Bipolar Disorder market landscape? Identify, understand and capitalize
Table of Contents
1.1 List of Tables 1.2 List of Figures 2 Introduction 2.1 Catalyst 2.2 Related Reports 2.3 Upcoming Related Reports 3 Market Outlook 3.1 Global Markets 3.1.1 Forecast 3.1.2 Drivers and Barriers - Global Issues 4 Current and Future Players 4.1 Overview 4.2 Trends in Corporate Strategy 4.3 Company Profiles 4.3.1 Otsuka 4.3.2 AstraZeneca 4.3.3 Eli Lilly 4.3.4 Allergan 4.3.5 Dainippon Sumitomo 4.3.6 Janssen 4.3.7 Lundbeck 4.3.8 Meiji Seika 5 Appendix 5.1 Bibliography 5.2 Abbreviations 5.3 Methodology 5.4 Forecasting Methodology 5.4.1 Diagnosed Bipolar Disorder Patients 5.4.2 Percent Drug-Treated Patients 5.4.3 Launch and Patent Expiry Dates 5.4.4 General Pricing Assumptions 5.4.5 Individual Drug Assumptions 5.4.6 Generic Erosion 5.5 Primary Research - KOLs Interviewed for this Report 5.6 Primary Research - Prescriber Survey 5.7 About the Authors 5.7.1 Analyst 5.7.2 Therapy Area Director 5.7.3 Epidemiologist 5.7.4 Global Director of Therapy Research and Analysis 5.8 About GlobalData 5.9 Disclaimer
List of Tables
Table 1: Global Sales Forecast ($m) for Bipolar Disorder, 2014-2024 Table 2: Bipolar Disorder Market - Drivers and Barriers, 2014-2024 Table 3: Key Companies in the Bipolar Disorder Market in the 8MM, 2015 Table 4: Otsuka's Bipolar Disorder Portfolio Assessment, 2015 Table 5: AstraZeneca's Bipolar Disorder Portfolio Assessment, 2015 Table 6: Eli Lilly's Bipolar Disorder Portfolio Assessment, 2015 Table 7: Allergan's Bipolar Disorder Portfolio Assessment, 2015 Table 8: Dainippon Sumitomo's Bipolar Disorder Portfolio Assessment, 2015 Table 9: Janssen Bipolar Disorder Portfolio Assessment, 2015 Table 10: Lundbeck Bipolar Disorder Portfolio Assessment, 2015 Table 11: Meiji Seika Bipolar Disorder Portfolio Assessment, 2015 Table 12: Key Launch Dates Table 13: Key Patent Expiries Table 14: High-Prescribing Physicians (Non-KOLs) Surveyed, By Country
List of Figures
Figure 1: Global Sales for Bipolar Disorder by Region, 2014-2024 Figure 2: Global Sales for Bipolar Disorder by Drug Class, 2014-2024 Figure 3: Global Sales of Products for Bipolar Disorder by Company, 2014-2024 Figure 4: Company Portfolio Gap Analysis in Bipolar Disorder, 2014-2024 Figure 5: Otsuka SWOT Analysis in Bipolar Disorder, 2014-2024 Figure 6: AstraZeneca SWOT Analysis in Bipolar Disorder, 2014-2024 Figure 7: Eli Lilly SWOT Analysis in Bipolar Disorder, 2014-2024 Figure 8: Allergan SWOT Analysis in Bipolar Disorder, 2014-2024 Figure 9: Dainippon Sumitomo SWOT Analysis in Bipolar Disorder, 2014-2024 Figure 10: Janssen SWOT Analysis in Bipolar Disorder, 2014-2024 Figure 11: Lundbeck SWOT Analysis in Bipolar Disorder, 2014-2024 Figure 12: Meiji Seika SWOT Analysis in Bipolar Disorder, 2014-2024
Global aquafeed market size is anticipated to be valued at USD 165.04 billion by 2022, as per a new research report by Radiant Insights, Inc. Increase in fish consumption for direct and indirect consumer applications is anticipated to drive the markeRead More...
Global Aerial Work Platform (AWP) truck market is expected to be valued at USD 8,003.7 million by 2022, as per a new research report by Radiant Insights, Inc. Rapid infrastructure growth due to rising real estate investment is expected to drive the iRead More...
Global gold nanoparticles market size is expected to reach 4.99 billion by 2020, witnessing gains at a CAGR of 24.7%. Positive outlook towards the increasing applications of nanotechnology in medical and dentistry such as drug delivery systems, nanomRead More...
Global embedded system market is projected to be valued at USD 214.39 billion by 2020, as per a new research report by Radiant Insights, Inc. Rising demand from end-use industries such as automotive and healthcare coupled with emergence of Internet oRead More...
Global alpha olefins market size is likely to be valued at USD 10.7 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing polyethylene demand for use in plastic production is anticipated to drive market growth. Growing apRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.